CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data

Jacob D. Soumerai, Stephen Opat, Chan Y. Cheah, Masa Lasica, Emma Verner, Peter J. Browett, Henry Chan, Eva González Barca, James Hilger, Yiqian Fang, David Simpson, Constantine S. Tam

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'CLL-118 A Phase 1 Study With the Novel B-Cell Lymphoma 2 Inhibitor BGB-11417 as Monotherapy or in Combination With Zanubrutinib in Patients With B-Cell Malignancies: Preliminary Data'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science